Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Nov 21, 2018 (8 years ago)

Norepinephrine 8 mg

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride

Cause type: Other

Recalls whose stated reason does not fall into the categories above. See the recall's own reason text for the specifics. All other recalls.

What was recalled

Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma 1075 West Park One Drive Suite 100 Sugar Land, TX 77478. Product Code 70092-9035-05

Affected NDC 70092-9035-05

Compare with the code on your package — it is the most precise check available.

Drug: Epinephrine

Recalling firm
QuVa Pharma, Inc.
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0295-2019 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Epinephrine recalls

See all
Class I · High risk

Epinephrine Injection

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Ongoing Sterility / contamination American Regent, Inc. NDC 0517-3030-01 D-0865-2026
Class II · Moderate risk

Maximum

Stability Data Does Not Support Expiry Date.

Ongoing Stability / shelf life HTO Nevada Inc. dba Kirkman D-0387-2026

Other recalls by QuVa Pharma, Inc.

All 2018 recalls